PTPN11 and Noonan syndrome: It has been shown that Shp2 homozygous deletion results in embryonic lethality due to the lack of ERK activation12, whereas a number of Noonan syndrome mouse models have demonstrated the contribution of Shp2-mediated ERK hyper-activation to the disease phenotype13, 14, 15.